{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:56:04Z","timestamp":1761947764782},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,10,19]],"date-time":"2011-10-19T00:00:00Z","timestamp":1318982400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s12282-011-0304-3","type":"journal-article","created":{"date-parts":[[2011,10,18]],"date-time":"2011-10-18T11:59:56Z","timestamp":1318939196000},"page":"90-94","source":"Crossref","is-referenced-by-count":6,"title":["A case of femoral diaphyseal fracture after long-term treatment with zoledronic acid"],"prefix":"10.1007","volume":"22","author":[{"given":"Kazuo","family":"Ishizuna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Ota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Fukuuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Teraoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsunehiro","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,10,19]]},"reference":[{"key":"304_CR1","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1056\/NEJM199612123352401","volume":"335","author":"GN Hortobagyi","year":"1996","unstructured":"Hortobagyi GN, Theriault RL, Porter L. Efficacy of pamidronate in reducing skeletal complication in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group. N Engl J Med. 1996;335:1785\u201391.","journal-title":"N Engl J Med"},{"key":"304_CR2","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1200\/JCO.1996.14.9.2552","volume":"14","author":"PF Conte","year":"1996","unstructured":"Conte PF, Latreille J, Mauriac L. Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational randomized controlled trial. The Areda Multinational Cooperative Group. J Clin Oncol. 1996;14:2552\u20139.","journal-title":"J Clin Oncol"},{"key":"304_CR3","first-page":"3383","volume":"19","author":"R Hultborn","year":"1999","unstructured":"Hultborn R, Gundersen S, Ryden S. Efficacy of pamidronate in breast cancer with bone metastases: a randomized, double-blind placebo-controlled multicenter study. Anticancer Res. 1999;19:3383\u201392.","journal-title":"Anticancer Res"},{"key":"304_CR4","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1200\/JCO.1999.17.3.846","volume":"17","author":"RL Theriault","year":"1999","unstructured":"Theriault RL, Lipton A, Hortobagyi GN. Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group. J Clin Oncol. 1999;17:846\u201354.","journal-title":"J Clin Oncol"},{"key":"304_CR5","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1200\/JCO.1998.16.6.2038","volume":"16","author":"GN Hortobagyi","year":"1998","unstructured":"Hortobagyi GN, Theriault RL, Lipton A. Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group. J Clin Oncol. 1998;16:2038\u201344.","journal-title":"J Clin Oncol"},{"key":"304_CR6","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1200\/JCO.2005.05.116","volume":"23","author":"N Kohno","year":"2005","unstructured":"Kohno N, Aogi K, Minami H. Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trial. J Clin Oncol. 2005;23:3314\u201321.","journal-title":"J Clin Oncol"},{"key":"304_CR7","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","volume":"90","author":"CV Odvina","year":"2005","unstructured":"Odvina CV, Zerwekh JE, Rao DS. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab. 2005;90:1294\u2013301.","journal-title":"J Clin Endocrinol Metab"},{"key":"304_CR8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.injury.2007.08.036","volume":"39","author":"EB Kwek","year":"2008","unstructured":"Kwek EB, Goh SK, Koh JS. An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy? Injury. 2008;39:224\u201331.","journal-title":"Injury"},{"key":"304_CR9","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/BOT.0b013e318172841c","volume":"22","author":"AS Neviaser","year":"2008","unstructured":"Neviaser AS, Lane JM, Lenart BA. Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma. 2008;22:346\u201350.","journal-title":"J Orthop Trauma"},{"key":"304_CR10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2265.2009.03581.x","volume":"72","author":"CV Odvina","year":"2009","unstructured":"Odvina CV, Levy S, Rao S. Unusual mid-shaft fractures during long-term bisphosphonate therapy. Clin Endocrinol. 2009;72:161\u20138.","journal-title":"Clin Endocrinol"},{"key":"304_CR11","first-page":"484","volume":"13","author":"RK Cheung","year":"2007","unstructured":"Cheung RK, Leung KK, Lee KC. Sequential non-traumatic femoral shaft fractures in a patient on long-term alendronate. Hong Kong Med J. 2007;13:484\u20139.","journal-title":"Hong Kong Med J"},{"key":"304_CR12","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/ageing\/afp106","volume":"38","author":"T Ali","year":"2009","unstructured":"Ali T, Jay RH. Spontaneous femoral shaft fracture after long-term alendronate. Age Ageing. 2009;38:625\u20136.","journal-title":"Age Ageing"},{"key":"304_CR13","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00198-009-0986-y","volume":"21","author":"MH Edwards","year":"2010","unstructured":"Edwards MH, McCrae FC, Young-Min SA. Alendronate-related femoral diaphysis fracture-what should be done to predict and prevent subsequent fracture of the contralateral side? Osteoporos Int. 2010;21:701\u20133.","journal-title":"Osteoporos Int"},{"key":"304_CR14","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1056\/NEJMc0707493","volume":"358","author":"BA Lenart","year":"2008","unstructured":"Lenart BA, Lorich DG, Lane JM. Atypical fractures of femoral diaphysis in postmenopausal women taking alendronate. N Engl J Med. 2008;358:1304\u20136.","journal-title":"N Engl J Med"},{"key":"304_CR15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00223-009-9263-5","volume":"85","author":"R Armamento-Villareal","year":"2009","unstructured":"Armamento-Villareal R, Napoli N, Diemer K. Bone turnover in bone biopsies of patients with low-energy cortical fractures receiving bisphosphonates: a case series. Calcif Tissue Int. 2009;85:37\u201344.","journal-title":"Calcif Tissue Int"},{"key":"304_CR16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11420-008-9077-4","volume":"4","author":"G Wernecke","year":"2008","unstructured":"Wernecke G, Namburi S, DiCarlo EF. Case report of spontaneous, nonspinal fractures in a multiple myeloma patient on long-term pamidronate and zoledronic acid. HSSJ. 2008;4:123\u20137.","journal-title":"HSSJ"},{"key":"304_CR17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S8756-3282(99)00116-7","volume":"25","author":"RG Russell","year":"1999","unstructured":"Russell RG, Rogers MJ. Bisphosphonates: from the laboratory to the clinic and back again. Bone. 1999;25:97\u2013106.","journal-title":"Bone"},{"key":"304_CR18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1177\/036354658201000407","volume":"10","author":"JE Butler","year":"1982","unstructured":"Butler JE, Brown SL, McConnell BG. Subtrochanteric stress fractures in runners. Am J Sports Med. 1982;10:228\u201332.","journal-title":"Am J Sports Med"},{"key":"304_CR19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.joms.2006.10.061","volume":"65","author":"T Mavrokokki","year":"2007","unstructured":"Mavrokokki T, Cheng A, Stein B. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg. 2007;65:415\u201323.","journal-title":"J Oral Maxillofac Surg"},{"key":"304_CR20","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1359\/jbmr.2003.18.3.512","volume":"18","author":"S Komatsubara","year":"2003","unstructured":"Komatsubara S, Mori S, Mashiba T. Long-term treatment of incadronate disodium accumulates microdamage but improves the trabecular bone microarchitecture in dog vertebra. J Bone Miner Res. 2003;18:512\u201320.","journal-title":"J Bone Miner Res"},{"key":"304_CR21","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1359\/JBMR.040126","volume":"19","author":"S Komatsubara","year":"2004","unstructured":"Komatsubara S, Mori S, Mashiba T. Suppressed bone turnover by long-term bisphosphonate treatment accumulates microdamage but maintains intrinsic material properties in cortical bone of dog rib. J Bone Miner Res. 2004;19:999\u20131005.","journal-title":"J Bone Miner Res"},{"key":"304_CR22","unstructured":"Dell R, et al. A retrospective analysis of all atypical femur fractures seen in a large Californian HMO from the years 2007 to 2009. ASBMR 2010 Annual Meeting, Toronto."},{"key":"304_CR23","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa1001086","volume":"362","author":"DM Black","year":"2010","unstructured":"Black DM, Kelly MP, Genant HK. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med. 2010;362:1761\u201371.","journal-title":"N Engl J Med"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-011-0304-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12282-011-0304-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-011-0304-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T22:23:46Z","timestamp":1560810226000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12282-011-0304-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,19]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["304"],"URL":"https:\/\/doi.org\/10.1007\/s12282-011-0304-3","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,19]]}}}